Akanda Corp (AKAN)
NASDAQ NMS - GLOBAL MARKET · Drug Manufacturers - Specialty & Generic
$6.20-0.11 (-1.74%)Quote refreshed
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Market Cap
$4.9M
P/E (TTM)
—
EPS
—
Div Yield
—
52W Range
—
Beta
—
Company overview
No company overview is available for Akanda Corp yet.
Peers in Drug Manufacturers - Specialty & Generic
All in industry →TAK#1
Takeda Pharmaceutical Company Limited
$57.78B-1.07%
ZTS#2
Zoetis Inc.
$50.46B+0.20%
HLN#3
Haleon plc
$43.61B+0.40%
TEVA#4
Teva Pharmaceutical Industries Limited
$36.05B+1.44%
UTHR#5
United Therapeutics Corporation
$25.19B-1.19%
VTRS#6
Viatris Inc.
$15.85B+0.29%
RGC#7
Regencell Bioscience Holdings Limited
$13.93B-2.46%
NBIX#8
Neurocrine Biosciences, Inc.
$13.21B-1.13%
ELAN#9
Elanco Animal Health Incorporated
$11.66B-0.59%
RDY#10
Dr. Reddy's Laboratories Limited
$10.92B+0.15%
Recent press releases
Akanda Corp has not issued a press release in this window.
SEC filings
All filings →Akanda Corp has not filed an SEC document in this window.
Insider trades
All insider trades →Akanda Corp has no reported insider trades in the last 90 days.
Institutional holders
All holders →As of 2025-12-31 · prior 2025-09-30
StoneX Group Inc.$7,701
16,840 sh● NEW
JANE STREET GROUP, LLC$4,942
10,807 sh● NEW
10,000 sh● NEW
UBS Group AG$3,008
6,581 sh● NEW
47,592 sh● NEW
People at Akanda Corp
All people →Quarterly financials
Full financials →Revenue trend
12/24
—
NI —
RevenueNI = Net Income
EPS trend (diluted)
EPS history not available.